Evaluating feasibility and efficiency of phase II adaptive platform trial designs based on the individualized screening trial of innovative glioblastoma therapy (INSIGhT)) experience Meeting Abstract
| Authors: | Rahman, R.; Trippa, L.; Lee, E. Q.; Arrillaga-Romany, I.; Touat, M.; Fell, G.; McCluskey, C.; Bruno, J.; Gaffey, S.; Drappatz, J.; Lassman, A.; Galanis, E.; Ahluwalia, M.; Colman, H.; Nabors, L. B.; Hepel, J.; Elinzano, H.; Schiff, D.; Chukwueke, U.; Beroukhim, R.; Batchelor, T.; Nayak, L.; McFaline-Figueroa, J. R.; Rinne, M.; Kaley, T.; Lu-Emerson, C.; Bi, W. L.; Arnaout, O.; Haas-Kogan, D.; Tanguturi, S.; Cagney, D.; Aizer, A.; Welch, M.; Doherty, L.; Lavallee, M.; Fisher-Longden, B.; Dowling, S.; Pisano, W.; Lapinskas, E.; Meredith, D.; Chiocca, E. A.; Reardon, D.; Ligon, K.; Alexander, B.; Wen, P. |
| Abstract Title: | Evaluating feasibility and efficiency of phase II adaptive platform trial designs based on the individualized screening trial of innovative glioblastoma therapy (INSIGhT)) experience |
| Meeting Title: | 26th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 23 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2021 Nov 18-21 |
| Meeting Location: | Boston, MA |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-11-01 |
| Start Page: | vi68 |
| End Page: | vi69 |
| Language: | English |
| ACCESSION: | WOS:000757356200267 |
| PROVIDER: | wos |
| DOI: | 10.1093/neuonc/noab196.265 |
| Notes: | Meeting Abstract: CTNI-40 -- Source: Wos |
